David A. Williams, MD is the Division Chief of Hematology/Oncology and the Director of Translational Research at Boston Children’s Hospital, the Associate Chairman of the Department of Pediatric Oncology at Dana-Farber Cancer Institute, and the Leland Fikes Professor of Pediatrics at Harvard Medical School. He earned his medical degree from Indiana University School of Medicine and completed his residency at Cincinnati Children’s Hospital Medical Center.
Before becoming ASH Vice President in 2013, Dr. Williams held numerous Society positions, including Councillor and member of the Translational Research Training in Hematology program Joint Oversight Committee. In addition to his service to ASH, Dr. Williams has served as an advisor to the National Institutes of Health (NIH), specifically as a member of the NIH Recombinant DNA Advisory Committee and Gene Therapy Safety Assessment Board. He has also served as Editor-In-Chief of Molecular Therapy and was a Howard Hughes Medical Institute Investigator for 16 years.
Dr. Williams’ basic research has focused on hematopoietic stem cell biology, including genetic diseases of the blood and specifically molecular and biochemical analysis of the interaction between hematopoietic stem cells and the bone marrow supporting environment. He has been the Principal Investigator, Co-Investigator, and/or sponsor of multiple human gene therapy trials and is actively involved in gene therapy trials for immunodeficiency and neurological genetic diseases. Dr. Williams has published more than 250 peer-reviewed manuscripts and textbook chapters. In addition to his active research, Dr. Williams continues to care for patients and co-leads the Fanconi Anemia and Bone Marrow Failure Multidisciplinary Clinic at Boston Children’s Hospital.
In addition to receiving the ASH William Dameshek Prize in 2000, Dr. Williams has received other prestigious awards from the Society for Pediatric Research, the American Society of Pediatric Hematology Oncology, the International Society of Experimental Hematology, and the American Society of Gene and Cell Therapy. He is a member of the National Academy of Science’s Institute of Medicine and is a Fellow of the American Association for the Advancement of Science.
back to top